Update on EGFR-mutated non-small cell lung cancer

Hae kokoteksti

CompEx asthma a novel composite exacerbation endpoint /

Hae kokoteksti
Series

Immunotherapy insights from advanced disease /

Hae kokoteksti
Series

Ovarian cancer progression of tumors /

Hae kokoteksti
Series

The evolving role of novel and next generation therapies in the management of multiple myeloma part 1 of 2, introduction and current therapies /

Hae kokoteksti

The evolving role of novel and next generation therapies in the management of multiple myeloma part 2 of 2, relapse refractory multiple myeloma /

Hae kokoteksti

Clinical trial designs for rare diseases part 1 of 2, trial designs /

Hae kokoteksti

Clinical trial designs for rare diseases part 2 of 2, trial protocols /

Hae kokoteksti

Management of sickle cell disease what to do when there is no evidence base /

Hae kokoteksti

Research & development of new pharmaceuticals for treatment of endometriosis

Hae kokoteksti

Lysosomal storage diseases

Hae kokoteksti
Series

Latest developments & future directions in the management of chronic pain

Hae kokoteksti
Series

Systemic lupus erythematosus novel aspects of pathogenesis and treatment, part 2 of 2 /

Hae kokoteksti
Series

GPCRs and pain

Hae kokoteksti
Series

Novel approaches to treating symptoms and slowing the progress of neurodegenerative diseases

Hae kokoteksti
Series

Multiple myeloma an overview /

Hae kokoteksti

Prolactin has a pathogenic role in systemic lupus erythematosus

Hae kokoteksti
Series

Advances in the treatment of NASH

Hae kokoteksti

Adapting proteostasis to ameliorate aggregation-associated amyloid diseases

Hae kokoteksti
Series

Pharmacotherapy for obesity part 1, the need for pharmacotherapy in weight management /

Hae kokoteksti